Top Rheumatoid Arthritis News
Keep up to date on all the latest Rheumatoid Arthritis research, drugs, and treatment.
-
Johns Hopkins moves to advance its autoimmune disease research
Johns Hopkins University's School of Medicine has purchased a type of technology that is used to detect markers of autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, lupus, and autoimmune hepatitis. Read Summary > -
Democrats demand info on sudden drug price hikes
Two senior Democrats in the U.S. House of Representatives have demanded a government investigation into a recent estimated nine percent increase in the prices of some of the most commonly used brand-name prescription drugs. Read Summary > -
Patients happier when docs discuss treatment side effects: study
Results from a new study suggest that hospital patients who suffer a side effect from treatment are more likely to give high ratings to their care when hospital staff are forthcoming with information about what went wrong with the treatment. Read Summary > -
New federal law prohibits genetic discrimination
The Genetic Information Nondiscrimination Act forbids employers and health insurance companies from making employment, coverage, and rate decisions based on a person's genetic makeup. Read Summary > -
Depressed pain patients more likely to get opioids: study
According to a new study, chronic pain patients who suffer from depression are more likely to be prescribed narcotic painkillers such as morphine and codeine. Read Summary > -
RA sufferer files discrimination lawsuit
Maintenance worker Gregory Miller has filed a disability discrimination lawsuit against a South Dakota company, claiming he was fired because he suffers from rheumatoid arthritis (RA). Read Summary > -
Clinical trial: Add-on treatment for osteoarthritis pain
Call for adults ages 40 years to 80 years old who have osteoarthritis to participate in a study. Read Summary > -
FDA accepts application for new OA drug
The U.S. Food and Drug Administration (FDA) has accepted a French drugmaker's new drug application for its experimental osteoarthritis drug naproxcinod. Read Summary >
